Berman Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	$11K	Buy	+100	New	+$11K	﹤0.01%	1149
2019 Q3	–	Sell	-200	Closed	-$9K	–	1465
2019 Q2	$9K	Buy	+200	New	+$9K	﹤0.01%	761